Online
Glenmark Pharma
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Pharmaceuticals
 |
| Profit & Loss account | ------------------- in Rs. Cr. ------------------- |
| Mar '04 | Mar '05 | Mar '06 | Mar '07 | Mar '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Income | ||||||||||
| Sales Turnover | 381.42 | 538.13 | 620.83 | 838.75 | 1,413.32 | |||||
| Excise Duty | 30.84 | 42.69 | 55.50 | 28.96 | 33.49 | |||||
| Net Sales | 350.58 | 495.44 | 565.33 | 809.79 | 1,379.83 | |||||
| Other Income | 2.61 | 3.78 | 14.38 | 18.24 | 1.40 | |||||
| Stock Adjustments | 21.88 | 23.76 | -1.33 | 50.80 | 30.20 | |||||
| Total Income | 375.07 | 522.98 | 578.38 | 878.83 | 1,411.43 | |||||
| Expenditure | ||||||||||
| Raw Materials | 127.67 | 181.58 | 200.45 | 309.56 | 467.47 | |||||
| Power & Fuel Cost | 3.14 | 7.41 | 8.66 | 15.17 | 17.02 | |||||
| Employee Cost | 38.83 | 49.49 | 60.11 | 78.21 | 108.91 | |||||
| Other Manufacturing Expenses | 9.98 | 16.61 | 18.26 | 16.86 | 20.52 | |||||
| Selling and Admin Expenses | 101.46 | 130.14 | 147.61 | 187.58 | 252.80 | |||||
| Miscellaneous Expenses | 20.50 | 19.11 | 23.07 | 37.81 | 40.44 | |||||
| Preoperative Exp Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total Expenses | 301.58 | 404.34 | 458.16 | 645.19 | 907.16 | |||||
| Mar '04 | Mar '05 | Mar '06 | Mar '07 | Mar '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Operating Profit | 70.88 | 114.86 | 105.84 | 215.40 | 502.87 | |||||
| PBDIT | 73.49 | 118.64 | 120.22 | 233.64 | 504.27 | |||||
| Interest | 10.06 | 16.73 | 17.45 | 39.36 | 43.64 | |||||
| PBDT | 63.43 | 101.91 | 102.77 | 194.28 | 460.63 | |||||
| Depreciation | 10.89 | 14.98 | 17.48 | 23.46 | 29.44 | |||||
| Other Written Off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Profit Before Tax | 52.54 | 86.93 | 85.29 | 170.82 | 431.19 | |||||
| Extra-ordinary items | 0.00 | 0.00 | 0.00 | -2.04 | 0.00 | |||||
| PBT (Post Extra-ord Items) | 52.54 | 86.93 | 85.29 | 168.78 | 431.19 | |||||
| Tax | 10.54 | 23.45 | 18.00 | 33.97 | 42.16 | |||||
| Reported Net Profit | 42.00 | 63.48 | 67.30 | 134.80 | 389.02 | |||||
| Total Value Addition | 173.91 | 222.77 | 257.70 | 335.63 | 439.68 | |||||
| Preference Dividend | 1.05 | 0.71 | 1.40 | 0.69 | 0.00 | |||||
| Equity Dividend | 7.70 | 8.30 | 8.31 | 9.58 | 17.15 | |||||
| Corporate Dividend Tax | 1.12 | 1.26 | 1.36 | 1.44 | 2.92 | |||||
| Per share data (annualised) | ||||||||||
| Shares in issue (lakhs) | 592.46 | 1,186.21 | 1,187.21 | 1,200.58 | 2,487.26 | |||||
| Earning Per Share (Rs) | 6.91 | 5.29 | 5.55 | 11.17 | 15.64 | |||||
| Equity Dividend (%) | 65.00 | 35.00 | 35.00 | 40.00 | 70.00 | |||||
| Book Value (Rs) | 37.99 | 22.48 | 25.16 | 37.50 | 41.34 | |||||
| ||||||||||
| Source : Asian CERC | ||||||||||
| ||||||||||